BlueWillow Biologics® is developing and enabling a new generation of safe and effective nasal vaccines to protect global populations from respiratory infections, sexually transmitted diseases, and food allergies. Our novel intranasal NanoVax® adjuvant platform activates mucosal immunity, the body’s first line of defense, while also inducing systemic immunity. We are a clinical-stage company advancing a pipeline of proprietary programs including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV.
Company Details
- Employees
- 22
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bluewillow.com
Bluewillow Biologics, Inc. Questions
Bluewillow Biologics, Inc.'s website is http://www.bluewillow.com
Bluewillow Biologics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/bluewillowbiologics
Bluewillow Biologics, Inc. has
22 employees.
View email and phone details for 22
employees at Bluewillow Biologics, Inc..
Bluewillow Biologics, Inc.'s industry is
Biotechnology Research
Bluewillow Biologics, Inc.'s top competitors are
Odyssey Therapeutics,
Mdi Therapeutics, Inc.,
Tsrl, Inc,
Diapin Therapeutics Inc,
Sling Therapeutics,
Anchorbio Solutions,
Nanobiotix,
Onl Therapeutics,
Evoq Therapeutics,
Strata Oncology.
Bluewillow Biologics, Inc.'s categories are Biotechnology Research
